News from merck serono s a A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

15 Nov, 2013, 07:00 GMT Merck Strengthens its Presence in China with New Pharmaceutical Manufacturing Facility

€ 80 million investment underscores Merck's long-term commitment to China New facility will focus on Merck's leading brands referenced in China's...


30 May, 2013, 08:00 BST Merck Serono: Update on Redeployment of Geneva Employees and the Company's Presence in Switzerland

The job prospects for 77% of former Geneva-based employees have been resolved Merck Serono retains a substantial and strategic presence in...


15 Apr, 2013, 09:42 BST Merck Serono's EPP to Finance the Launch of the EspeRare Foundation, a Nonprofit Organization to Advance Treatments for Rare Diseases

Merck Serono to endow the EspeRare Foundation with a €2.8 million funding and the rights to a former Merck Serono compound to be actively...


04 Mar, 2013, 13:33 GMT Sixth Merck Serono Spin-off Company to Focus on Gastrointestinal Immunological Disorders

Newly formed Calypso Biotech will continue research and development of preclinical antibody programs from Merck Serono Merck Serono, a division of...


05 Feb, 2013, 12:30 GMT Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™(imilecleucel-T) for Treatment of Multiple Sclerosis

Merck Serono granted option for exclusive license from Opexa to develop and commercialize Tcelna (imilecleucel-T), an investigational T-cell therapy...


30 Jan, 2013, 08:00 GMT Update on Redeployment of Merck Serono Employees in Geneva

The job prospects of approximately 750 employees - i.e. 6 people out of 10 - have been resolved Merck Serono today provided an update on the...


29 Jan, 2013, 14:13 GMT Merck Serono and Feinstein Institute to Partner on Pre-clinical Program in Inflammatory Diseases

Collaboration to focus on research and development of antibodies for the treatment of systemic lupus erythematosus (SLE) Merck Serono, a division of...


23 Jan, 2013, 08:30 GMT Merck Serono Announces the Creation of Ondaco, the Fifth Company Stemming From its Entrepreneur Partnership Program

With an experienced team of sixteen employees, Ondaco will manage IT support services and application development for all Merck Serono sites based in ...


15 Jan, 2013, 08:35 GMT Launch of TQM Insight, an IT Service Company Formed Through Merck Serono's Entrepreneur Partnership Program

TQM Insight will offer governance services and products with a focus on Information Technology (IT) for organizations in regulated industries Merck...


03 Jan, 2013, 15:08 GMT Merck Serono Announces FDA Approval of Rebif® Rebidose® (interferon beta-1a)

Merck Serono, a division of Merck, Darmstadt, Germany, announced that the U.S. Food and Drug Administration (FDA) approved Rebif® Rebidose®...


04 Dec, 2012, 08:00 GMT Merck Serono Executives Donate Time to Charity to Benefit Wateraid International

Charity auction will give individuals from life sciences industry opportunity to bid for private lunch with senior executives from biopharma Merck...


29 Nov, 2012, 12:35 GMT Merck Serono Donates 100 Millionth Tablet to Treat Schistosomiasis

Large-scale schistosomiasis treatment begins in Kenya Merck Serono, a division of Merck, Darmstadt, Germany, today symbolically donated the 100...


28 Nov, 2012, 09:00 GMT Merck Serono Advances to Eighth Place in the 2012 Access to Medicine Index

Merck Serono, a division of Merck, Darmstadt, Germany, moves up nine places from previous rank 17 (out of 20), thanks to scaled-up efforts in its...


18 Oct, 2012, 14:13 BST Merck Serono and Auxogyn Announce Collaboration on Eeva™ Test

The Early Embryo Viability Assessment (Eeva) Test is designed to provide data that will help assess embryo viability Strategic partnership...


28 Sep, 2012, 08:30 BST Update on Redeployment of Merck Serono Employees in Geneva

Job prospects for more than 500 employees - or 40% of the total Geneva-based employees - have been clarified as of today Various redeployment...


10 Sep, 2012, 12:39 BST Merck Serono Organizes a Job Fair to Help with Redeployment for Geneva Employees

More than 30 companies operating in French-speaking Switzerland will attend Job fair is organized in collaboration with BioAlps, GEM and AIGSV Merck...


03 Sep, 2012, 07:30 BST Merck Serono Announces the Creation of Quartz Bio, a Bioinformatics Company Formed Through its Entrepreneur Partnership Program

Quartz Bio will offer highly specialized services to the pharmaceutical industry in the field of biomarker data analysis Merck Serono, a division of...


09 Aug, 2012, 17:03 BST Agreement Signed to Put an end to the Labor Dispute Over the Merck Serono Sites in Geneva and the Vaud Canton

Merck Serono will offer additional benefits aimed at providing greater support for the most economically vulnerable employees and facilitating the...


30 Jul, 2012, 08:19 BST Merck Serono Announces Creation of First Spin-Off Company From its Entrepreneur Partnership Program

Prexton Therapeutics Will Develop Merck Serono's Metabotropic Glutamate Receptors Programs for Parkinson's Disease Merck Serono, a division of Merck, ...


26 Jul, 2012, 08:00 BST Position of Merck Serono Concerning the Recommendation Made by CRCT of Geneva

Merck Serono has decided not to accept the recommendation regarding a supplementary increase in the redundancy payments to be made to all employees...


18 Jul, 2012, 21:13 BST Outcome of Conciliation Proceedings Conducted by the CRCT in Geneva

The final meeting of the conciliation proceedings between the management of Merck Serono and, representatives of the employees and the UNIA trade...


03 Jul, 2012, 07:00 BST Merck Serono Increases Commitment to the Grant for Fertility Innovation (GFI) Program to 4 Million Euros

Merck Serono, a division of Merck, Darmstadt, Germany, announced during the 28th annual meeting of the European Society of Human Reproduction and...


26 Jun, 2012, 08:00 BST Merck Serono Announces First Employment Initiative for Employees Affected by Restructuring in Switzerland

Biopharmaceutical services company Quintiles commits to make at least 100 employment offers exclusively to Merck Serono employees Merck Serono, a...


25 Jun, 2012, 12:00 BST Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd.

Neviah Genomics Ltd. to focus on the discovery and development of novel biomarkers for drug toxicity Compugen to utilize its predictive discovery...


21 Jun, 2012, 08:00 BST Merck Serono Celebrates the 50-Year Anniversary of Neurobion

Merck Serono is a pioneer[1] in vitamin-B combination supplements with Neurobion® indicated in the treatment of vitamin B1, B6 and B12 deficiencies....